JP2010529080A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010529080A5 JP2010529080A5 JP2010510782A JP2010510782A JP2010529080A5 JP 2010529080 A5 JP2010529080 A5 JP 2010529080A5 JP 2010510782 A JP2010510782 A JP 2010510782A JP 2010510782 A JP2010510782 A JP 2010510782A JP 2010529080 A5 JP2010529080 A5 JP 2010529080A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- disorder
- stereoisomers
- difluorophenyl
- pyrrolidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 16
- 150000003839 salts Chemical class 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 5
- KVTILWXFURUWHL-UHFFFAOYSA-N 3-(3,4-difluorophenyl)pyrrolidine Chemical compound C1=C(F)C(F)=CC=C1C1CNCC1 KVTILWXFURUWHL-UHFFFAOYSA-N 0.000 claims 4
- 150000001204 N-oxides Chemical class 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 208000028698 Cognitive impairment Diseases 0.000 claims 3
- 208000010877 cognitive disease Diseases 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 201000000980 schizophrenia Diseases 0.000 claims 3
- 208000011688 Generalised anxiety disease Diseases 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- 208000015114 central nervous system disease Diseases 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 208000029364 generalized anxiety disease Diseases 0.000 claims 2
- 208000019906 panic disease Diseases 0.000 claims 2
- QSBSGFHTQBDWJV-UHFFFAOYSA-N 3-(2,4-difluorophenyl)pyrrolidine Chemical compound FC1=CC(F)=CC=C1C1CNCC1 QSBSGFHTQBDWJV-UHFFFAOYSA-N 0.000 claims 1
- BZRNHMNSDPKKHM-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)pyrrolidine Chemical compound C1=C(Cl)C(Cl)=CC=C1C1CNCC1 BZRNHMNSDPKKHM-UHFFFAOYSA-N 0.000 claims 1
- QDXUCQPDXXXLPM-UHFFFAOYSA-N 3-(3,4-difluorophenyl)-1-methylpyrrolidine Chemical compound C1N(C)CCC1C1=CC=C(F)C(F)=C1 QDXUCQPDXXXLPM-UHFFFAOYSA-N 0.000 claims 1
- NSNPKCDGEORKKV-UHFFFAOYSA-N 3-(3,5-difluorophenyl)pyrrolidine Chemical compound FC1=CC(F)=CC(C2CNCC2)=C1 NSNPKCDGEORKKV-UHFFFAOYSA-N 0.000 claims 1
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims 1
- 208000020925 Bipolar disease Diseases 0.000 claims 1
- 206010012289 Dementia Diseases 0.000 claims 1
- 208000012239 Developmental disease Diseases 0.000 claims 1
- 208000027534 Emotional disease Diseases 0.000 claims 1
- 201000004311 Gilles de la Tourette syndrome Diseases 0.000 claims 1
- 208000012902 Nervous system disease Diseases 0.000 claims 1
- 206010034912 Phobia Diseases 0.000 claims 1
- 208000000323 Tourette Syndrome Diseases 0.000 claims 1
- 208000016620 Tourette disease Diseases 0.000 claims 1
- 208000029560 autism spectrum disease Diseases 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 206010008129 cerebral palsy Diseases 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000012895 dilution Substances 0.000 claims 1
- 238000010790 dilution Methods 0.000 claims 1
- 230000010249 dopaminergic function Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 230000004770 neurodegeneration Effects 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 claims 1
- 208000019116 sleep disease Diseases 0.000 claims 1
- 208000020685 sleep-wake disease Diseases 0.000 claims 1
- 201000001716 specific phobia Diseases 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
- 0 *c1cc(*)c(C2CN(*)CC2)cc1 Chemical compound *c1cc(*)c(C2CN(*)CC2)cc1 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94199307P | 2007-06-05 | 2007-06-05 | |
| SE0701386 | 2007-06-05 | ||
| PCT/EP2008/056912 WO2008148799A1 (en) | 2007-06-05 | 2008-06-04 | New disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010529080A JP2010529080A (ja) | 2010-08-26 |
| JP2010529080A5 true JP2010529080A5 (enExample) | 2011-07-21 |
Family
ID=39672106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010510782A Pending JP2010529080A (ja) | 2007-06-05 | 2008-06-04 | 皮質カテコールアミン作動性神経伝達の調節因子としての新規な二置換フェニルピロリジン |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20100197760A1 (enExample) |
| EP (1) | EP2155669B1 (enExample) |
| JP (1) | JP2010529080A (enExample) |
| CN (1) | CN101711234A (enExample) |
| AT (1) | ATE508110T1 (enExample) |
| AU (1) | AU2008258597A1 (enExample) |
| CA (1) | CA2689692A1 (enExample) |
| DE (1) | DE602008006720D1 (enExample) |
| MX (1) | MX2009012716A (enExample) |
| NZ (1) | NZ581363A (enExample) |
| WO (1) | WO2008148799A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2009012787A (es) | 2007-06-05 | 2009-12-15 | Nsab Af Neurosearch Sweden Ab | Nuevas fenilpirrolidinas disustituidas como moduladores de neurotransmision catecolaminergica cortical. |
| MX2011005034A (es) | 2008-11-24 | 2011-06-16 | Nsab Af Neurosearch Sweden Ab | Nuevos derivados de 3-fenil-azetidina utiles como moduladores de la neurotransmision catecolaminergica cortical. |
| MX2011005036A (es) | 2008-11-24 | 2011-06-16 | Nsab Af Neurosearch Sweden Ab | Derivados de 3-fenil-3metoxipirrolidina como moduladores de la neurotransmision catecolaminergia cortical. |
| JP6095234B2 (ja) * | 2011-03-31 | 2017-03-15 | シェブロン ユー．エス．エー． インコーポレイテッド | 脱蝋触媒の安定性及び潤滑油の収率を改良するための新規なプロセス及び触媒システム |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US364414A (en) * | 1887-06-07 | Gael hollweg | ||
| US2878264A (en) * | 1959-03-17 | Substituted amino alcohols | ||
| US3118907A (en) * | 1961-08-14 | 1964-01-21 | Mead Johnson & Co | 3-substituted-3-pyrrolidinols |
| US3647790A (en) * | 1969-04-08 | 1972-03-07 | American Home Prod | Ouinoxalinyl-oxazolidines and -oxazines |
| DE69231854T2 (de) * | 1991-04-17 | 2001-10-04 | Pharmacia & Upjohn Co., Kalamazoo | Substituierte (s)-3-phenylpiperidin derivate, deren herstellung und deren verwendung als dopamin autorezeptor antagonisten |
| US5129962A (en) * | 1991-10-22 | 1992-07-14 | International Business Machines Corporation | Tacky, no-clean thermally dissipated soldering flux |
| US20020169155A1 (en) * | 1998-09-04 | 2002-11-14 | Millennium Pharmaceuticals, Inc. | Chemokine receptor anagonists and methods of use therefor |
| SE9904724D0 (sv) | 1999-12-22 | 1999-12-22 | Carlsson A Research Ab | New modulators of dopamine neurotransmission I |
| SE9904723D0 (sv) | 1999-12-22 | 1999-12-22 | Carlsson A Research Ab | New modulators of dopamine neurotransmission II |
| TWI308976B (en) * | 2003-02-14 | 2009-04-21 | Chunghwa Picture Tubes Ltd | Process and structure of linquid crystal panel with one drop fill |
| PL1622569T3 (pl) * | 2003-04-24 | 2016-06-30 | Incyte Holdings Corp | Pochodne aza spiro alkanów jako inhibitory metaloproteaz |
| CA2551037A1 (en) * | 2003-09-22 | 2005-03-31 | Banyu Pharmaceutical Co., Ltd. | Novel piperidine derivative |
| TWI350168B (en) * | 2004-05-07 | 2011-10-11 | Incyte Corp | Amido compounds and their use as pharmaceuticals |
| KR100690854B1 (ko) * | 2005-11-08 | 2007-03-09 | 엘지전자 주식회사 | 멀티태스킹이 가능한 휴대용 단말기 및 그의 멀티태스킹처리방법 |
| ES2412007T3 (es) * | 2005-12-21 | 2013-07-09 | Janssen Pharmaceutica, N.V. | Derivados de pirazinona sustituida novedosos para uso en enfermedades mediadas por MCH-1 |
| US20080070649A1 (en) * | 2006-09-06 | 2008-03-20 | Uchida Toshi K | Free Space Optical Interconnections in Cellular Telephone Handsets |
-
2008
- 2008-06-04 JP JP2010510782A patent/JP2010529080A/ja active Pending
- 2008-06-04 NZ NZ581363A patent/NZ581363A/en unknown
- 2008-06-04 WO PCT/EP2008/056912 patent/WO2008148799A1/en not_active Ceased
- 2008-06-04 AU AU2008258597A patent/AU2008258597A1/en not_active Abandoned
- 2008-06-04 CN CN200880018786A patent/CN101711234A/zh active Pending
- 2008-06-04 MX MX2009012716A patent/MX2009012716A/es active IP Right Grant
- 2008-06-04 DE DE602008006720T patent/DE602008006720D1/de active Active
- 2008-06-04 EP EP08760493A patent/EP2155669B1/en not_active Not-in-force
- 2008-06-04 CA CA2689692A patent/CA2689692A1/en not_active Abandoned
- 2008-06-04 US US12/663,211 patent/US20100197760A1/en not_active Abandoned
- 2008-06-04 AT AT08760493T patent/ATE508110T1/de not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010529081A5 (enExample) | ||
| TR201904614T4 (en) | Novel pyrazole derivative. | |
| RU2009143104A (ru) | Новые двузамещенные фенилпирролидины в качестве модуляторов кортикальной катехоламинергической нейротрансмиссии | |
| RU2010119560A (ru) | Замещенные n-фенилбипирролидинкарбоксамиды и их терапевтическое применение | |
| JP2010505794A5 (enExample) | ||
| JP2011524850A5 (enExample) | ||
| JP2017522340A5 (enExample) | ||
| WO2009158467A3 (en) | Di-substituted phenyl compounds as phosphodiesterase 10 inhibitors | |
| JP2020500215A5 (enExample) | ||
| JP2011515482A5 (enExample) | ||
| JP2018519328A5 (enExample) | ||
| JP2012510437A5 (enExample) | ||
| PH12013501556A1 (en) | IMIDAZO[5,1-f][1,2,4]TRIAZINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | |
| JP2008513516A5 (enExample) | ||
| JP2019534327A5 (enExample) | ||
| EA200800430A1 (ru) | Замещённые тетрагидро-1н-пиридо[4,3,b] индолы как агонисты и антагонисты серотониновых рецепторов | |
| JP2012508734A5 (enExample) | ||
| JP2015500223A5 (enExample) | ||
| RU2015112914A (ru) | Бензимидазолы в качестве активных агентов для центральной нервной системы | |
| JP2019525939A5 (enExample) | ||
| RU2016131875A (ru) | Производные n-фениллактама, способные стимулировать нейрогенез, и их применение при лечении заболеваний нервной системы | |
| JP2017528515A5 (enExample) | ||
| WO2014087367A3 (en) | Compositions and methods for the treatment of neurological diseases and its associated complications | |
| JP2010529080A5 (enExample) | ||
| JP2012532125A5 (enExample) |